(1-(4-Aminophenyl)pyrrolidin-2-yl)methanol, 95%, 1g

2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 2.5g

N,N-Diethylacetamide>99.0%(GC)500mL

2-(BROMOMETHYL)-6-CHLOROPYRIDINE, 95.0%, 1g

N-Fmoc-N,O-dimethyl-L-serine, 98%, 5g

3-Amino-5-bromobenzoic acid, 95.0%, 25g

Tantalum(V) oxide tablets 99.95% ca. 8 x 4 mm 50 g

Ethyl 7-amino-5-chloro-1H-indole-2-carboxylate, 98%, 250mg

tert-butyl (2S,4R)-2-[4-(4-bromophenyl)-1H-imidazol-2-yl]-4-hydroxypyrrolidine-1-carboxylate, 95%, 250mg

Dibenzofuran-2-carboxaldehyde, 95.0%, 5g

TERT-BUTYL 3-AMINO-3-METHYLAZETIDINE-1-CARBOXYLATE, 95.0%, 50g

2-Cyano-N-(2-methoxyphenyl)acetamide, 97%, 5g

(1R,2R)-2-(1,3-dioxo-1,3-dihydro-2H-naphtho[2,3-f]isoindol-2-yl)cyclohexane-1-carboxylic acid, 98%, 100mg